Subacute stent thrombosis in a patient with COVID-19 pneumonia.
Mohamed AyanSwathi KovelamudiMalek Al-HawwasPublished in: Proceedings (Baylor University. Medical Center) (2020)
Acute and subacute stent thromboses are rare but life-threatening complications of primary coronary intervention and stenting. We present a case of a patient with COVID-19 infection who presented with pneumonia, acute respiratory failure, and non-ST elevation myocardial infarction. Reperfusion was achieved with coronary angioplasty and drug-eluting stent placement, and the patient was started on aspirin and clopidogrel. However, 72 hours later, the patient experienced an episode of subacute stent thrombosis. This raises concerns about a possible association between stent thrombosis and increased thrombogenicity and platelet aggregability triggered by COVID-19 infection.
Keyphrases
- respiratory failure
- case report
- st elevation myocardial infarction
- percutaneous coronary intervention
- pulmonary embolism
- extracorporeal membrane oxygenation
- coronary artery disease
- antiplatelet therapy
- liver failure
- coronary artery
- randomized controlled trial
- mechanical ventilation
- sars cov
- acute coronary syndrome
- drug induced
- risk factors
- cardiovascular events
- hepatitis b virus
- blood brain barrier
- acute ischemic stroke
- left ventricular
- subarachnoid hemorrhage
- community acquired pneumonia